深圳市宇顺电子股份有限公司公告，因2024年度净利润等指标不达标，自2025年5月6日起公司股票被实 施退市风险警示，若2025年出现特定情形将终止上市。公司正进行重大资产重组，存在审批、资金等多 项风险。截至9月10日，公司股票静态市盈率 -511.88倍、滚动市盈率 -658.25倍、市净率39.77倍，与同 行业差异大。此外，公司股票连续三个交易日涨幅偏离值累计超12%，属异常波动，提醒投资者注意投 资风险。 ...

Core Viewpoint - *ST Zitian has been ordered to delist from the Shenzhen Stock Exchange due to significant financial misconduct, including nearly 25 billion yuan in revenue falsification, which constitutes 63.53% of its reported revenue for 2022 and 2023 [1][2]. Group 1: Delisting Announcement - On September 5, *ST Zitian received a notice from the Shenzhen Stock Exchange regarding the termination of its stock listing, with trading set to resume on September 15 and a delisting period of 15 trading days [1]. - The expected last trading day is October 13, after which the stock will be transferred to a delisting segment managed by the National Equities Exchange and Quotations [1]. Group 2: Financial Misconduct - The company was found to have false records in its financial reports, leading to a directive from the China Securities Regulatory Commission (CSRC) for rectification, which was not completed within the required timeframe [1]. - The CSRC's notice indicated that the false revenue figures for 2022 and 2023 amounted to nearly 25 billion yuan, significantly impacting the company's financial integrity [2]. Group 3: Management Response - During the investigation, key management personnel, including the chairman and general manager, evaded communication with regulatory authorities, which was deemed a serious obstruction of the investigation [3]. - The general manager claimed to have been deceived by the financial director, who is a relative, as a reason for non-compliance with the investigation [4]. - The financial director cited illness as a reason for his inability to fulfill his duties during the investigation period [5].

Core Viewpoint - The company is facing severe operational and financial challenges, including judicial asset auctions and the dismantling of key production facilities, which jeopardize its ability to resume production by 2025 [1][2]. Group 1: Judicial Asset Auctions - The controlling shareholder, Jiangsu Shenshang, has had all 747 million shares judicially auctioned, with 1.96 million shares (0.04% of total shares) sold in the first auction and 6.74 million shares (0.13% of total shares) sold in the second auction [1]. - A total of 382 million shares (7.57% of total shares) were transferred to Jilin Jiutai Rural Commercial Bank after failing to sell in the first auction, and 7.44 million shares were also transferred after the second auction [1]. Group 2: Production and Operational Challenges - The T300 model assembly line of the subsidiary, Hunan Jiangnan Automobile Chongqing Branch, was forcibly dismantled by the court, which is a critical asset for the company's planned resumption of operations [1]. - The dismantling of this production line indicates that the company has completely lost its ability to resume production by 2025, significantly increasing the risk of continued operations [1]. Group 3: Financial Performance - For the first half of 2025, the company reported revenue of 280 million yuan, a year-on-year increase of 12.61%, but still incurred a net loss of 148 million yuan [2]. - The net loss was reduced by 42.82% compared to the previous year, primarily due to decreased financial expenses and asset impairment reversals [2]. - The net assets attributable to shareholders have plummeted by 62.85% to only 87.25 million yuan, raising concerns about potential delisting if net assets turn negative by year-end [2].

Core Viewpoint - The announcement from Xinhua Jin reveals significant fund occupation issues, amounting to 406 million yuan, by its major shareholder, Xinhua Jin Group, raising concerns among over 20,000 shareholders about potential delisting risks if the funds are not recovered in time [1][10]. Fund Occupation Issues - Xinhua Jin Group and its affiliates have occupied 406 million yuan of the company's funds, with the occupation period from January 1, 2025, to June 30, 2025 [3][10]. - As of the half-year report disclosure date, the balance of occupied funds remains at 406 million yuan, indicating a failure to repay [3][10]. - In the first half of 2025, Xinhua Jin Group and its affiliates occupied approximately 801 million yuan, with partial repayments made in April, but funds were subsequently reallocated due to financial pressures from strategic investors [4][6]. Repayment Plans - Xinhua Jin Group intends to use 665 million yuan from the sale of Jimo Yellow Wine to repay the occupied funds, with this receivable already pledged to the company, granting it priority in repayment [2][12]. - The completion of the acquisition of Jimo Yellow Wine by Qingdao Beer is crucial for the repayment, but uncertainties remain regarding the execution of the sale and repayment agreements [14]. Financial Performance - For the first half of 2025, Xinhua Jin reported revenues of approximately 669 million yuan, a year-on-year decline of 24.92%, and a net profit attributable to shareholders of about 12.87 million yuan, down 39.45% [6][9]. - The company's net assets at the end of the reporting period were approximately 1.22 billion yuan, reflecting a slight increase of 0.97% compared to the previous year [9]. Market Reaction - Following the announcement of the fund occupation, Xinhua Jin's stock price fell over 4%, with a total decline of 29.66% over six trading days since the news broke [14].

Core Viewpoint - Hubei Meirya Co., Ltd. has experienced significant stock price fluctuations, with a cumulative increase of 62.77% since August 14, 2025, leading to concerns about potential financial and regulatory risks [2][10]. Group 1: Stock Trading Anomalies - The company's stock price deviated significantly, with a cumulative closing price increase of over 12% during three consecutive trading days (August 29, September 1, and September 2, 2025) [2][4]. - The stock has triggered abnormal fluctuation limits three times since August 14, 2025, indicating severe deviation from the Shanghai Composite Index's performance [2][10]. Group 2: Financial Performance - In the first half of 2025, the company reported revenue of 129 million yuan and a net loss of 21.86 million yuan, continuing a trend of losses since 2022 [2][5]. - The company’s revenue for 2024 was 330 million yuan, reflecting a year-on-year decline of 27.42% [5]. Group 3: Audit and Compliance Issues - The auditing firm Zhongshun Zhonghuan issued a qualified opinion on the company's 2024 financial report, and the internal control audit received a negative opinion, indicating significant deficiencies [3][12]. - If the 2025 internal control audit also receives a negative opinion, the company may face regulatory delisting warnings [12][13]. Group 4: Ongoing Investigations - The company and its chairman, Zheng Jiping, are currently under investigation by the China Securities Regulatory Commission, with uncertain outcomes [3][14].

Core Viewpoint - *ST Suwu (600200.SH) has experienced significant stock price volatility, with a shift from a limit down to a limit up on September 2, indicating potential irrational speculation and multiple delisting risks [1] Financial Performance - The company reported a net loss attributable to shareholders of 44.42 million yuan for the first half of 2025, a decline of 281.63% compared to the same period last year [1] Regulatory Issues - On July 13, 2025, the company received an administrative penalty notice from the China Securities Regulatory Commission, which identified false records in revenue, costs, and profits in the annual reports from 2020 to 2023, triggering major illegal delisting scenarios [1] Operational Risks - The company faces multiple risks, including significant fund occupation by the controlling shareholder, complete freezing of shares held by the controlling shareholder, and the termination of exclusive agency agreements for medical beauty products, leading to business stagnation [1] Delisting Risks - The company is at risk of financial delisting, par value delisting, and major illegal delisting due to the aforementioned issues [1]

Core Viewpoint - *ST Suwu (600200.SH) has experienced significant stock price volatility, with a shift from a limit down to a limit up on September 2, indicating potential irrational speculation and multiple delisting risks [1] Financial Performance - For the first half of 2025, the company reported a net profit attributable to shareholders of -44.42 million yuan, representing a 281.63% decrease compared to the same period last year [1] Regulatory Issues - The company received an administrative penalty notice from the China Securities Regulatory Commission on July 13, 2025, citing inflated revenue, costs, and profits, with false records in annual reports from 2020 to 2023, which may lead to mandatory delisting [1] Operational Risks - The company faces multiple risks, including significant fund occupation by the controlling shareholder, complete freezing of shares held by the controlling shareholder, and the termination of exclusive agency agreements for medical beauty products, resulting in business stagnation [1] Delisting Risks - There are various delisting risks for the company, including financial delisting, par value delisting, and mandatory delisting due to serious violations [1]

Core Viewpoint - *ST Gao Hong's stock price has fallen below 1 yuan for the first time, raising the risk of delisting due to its share price being below par value [1][2]. Group 1: Stock Price and Delisting Risk - On September 1, *ST Gao Hong announced that its stock closed at 0.98 yuan per share, marking the first time it has fallen below 1 yuan, which poses a risk of being delisted if the price remains below this threshold for 20 consecutive trading days [2][5]. - According to regulations, if a company listed on the Shenzhen Stock Exchange has its stock price below 1 yuan for 20 consecutive trading days, the exchange will terminate its listing without a delisting preparation period [2]. Group 2: Legal and Compliance Issues - *ST Gao Hong is facing significant internal control issues, with the potential for forced delisting due to major legal violations. The company received a notice from the China Securities Regulatory Commission (CSRC) on August 8, indicating that its 2020 private placement constituted fraudulent issuance and that its annual reports from 2015 to 2023 contained false records [3][4]. - If the CSRC's formal decision confirms that *ST Gao Hong has violated major legal provisions, the company will face delisting [3][4]. - The company has received adverse audit opinions regarding its financial reports for 2023 and has shown negative net profits for three consecutive years from 2021 to 2023, raising concerns about its ability to continue as a going concern [3][4]. Group 3: Financial Performance - As of September 1, *ST Gao Hong's total market capitalization is reported to be 1.1 billion yuan [5].

Group 1 - The stock of *ST Yuancheng (603388) closed at 2.25 yuan on September 1, 2025, with an increase of 1.81% and a turnover rate of 2.97%, totaling a trading volume of 96,900 hands and a transaction amount of 21.67 million yuan [1] - On September 1, 2025, the net inflow of main funds was 2.0273 million yuan, accounting for 9.36% of the total transaction amount, while retail investors experienced a net outflow of 1.4529 million yuan, representing 6.7% of the total transaction amount [1][3] - The company is under investigation by the China Securities Regulatory Commission (CSRC) for suspected false disclosures in its annual reports, which may lead to a significant risk of forced delisting if found guilty [1][3] Group 2 - For the first half of 2025, the company reported an operating income of 82.34 million yuan and a net profit attributable to shareholders of -126.80 million yuan, indicating continuous losses over the past three years [1] - The company has multiple frozen bank accounts with a total amount of 330.52 million yuan, which accounts for 39.02% of the latest audited net assets [1] - The company is required to disclose risk warning announcements monthly as the investigation is ongoing [1]

Core Viewpoint - *ST Gaohong's stock price closed at 0.98 yuan per share on September 1, marking the first time it has fallen below 1 yuan, which raises the risk of delisting due to the stock price being below par value [2][5]. Group 1: Delisting Risks - The company faces the risk of being delisted if its stock price remains below 1 yuan for 20 consecutive trading days, as per the regulations of the Shenzhen Stock Exchange [5]. - *ST Gaohong has received an administrative penalty notice from the China Securities Regulatory Commission (CSRC) regarding fraudulent issuance of stocks and false records in annual reports from 2015 to 2023, which may lead to mandatory delisting due to major violations [7][8]. Group 2: Financial and Operational Issues - The company has received adverse audit opinions from accounting firms regarding its internal controls and financial statements for the years 2021 to 2023, indicating a lack of certainty about its ability to continue as a going concern [7]. - As of September 1, the company's total market capitalization is 1.1 billion yuan, with its stock price at 0.98 yuan per share [8].